Coherus Oncology

CHRS

Last Price

08/18/25, 09:30 AM
 EDT
$
1.07
(
1.9
%)
(
+
1.9
%)

Margin of Safety

+
199.1
%
3.20
NASDAQ

Stock charts are coming!

Solt DB launched with awesome written research, bottom-up modeling, and Margin of Safety signals.

Interactive stock charts are the very next thing we're working on site-wide. Our stock charts will have additional data layers, such as flags for events, modeling refinements, and research notes; as well as historical modeled fair valuation.

Want to request new features? Don't like the position or look of something? Let us know -- we'll add or change it: invest@soltdb.com

Last Price

$
1.07

Margin of Safety

+
199.1
%

Est. Fair ValuE (PER share)

$
3.20

Portfolio Category

Future Compounder
CHRS

EST. Fair ValuE (PER share)

$
3.20

EST. Fair ValuE (MKT Cap)

$380 million

Last Refinement

August 7, 2025

Portfolio Category

Future Compounder

Allocation Suggestion

0% to 10%

Research Deep Dive

Last Updated:

Overview

Solt DB Invest will introduce Base Research for our coverage ecosystem over the next month to coincide with third-quarter 2023 earnings announcements. Check back soon!

Technology Platform

Pipeline

Portfolio

Opportunities & Advantages

Challenges & Risks

Development Risk 

Regulatory Risk 

Commercial Risk 

Dilution Risk 

Valuation Risk 

Geopolitical Risk 

Unique Risks 

Modeling Insights

News Flow & Timing